In fact, loss of Olig2 in NG2+ OPCs has been shown to increase differentiation into astrocytes at the expense of OLs (Zuo et al., 2018), and Olig2 deletion converts gliomas from proneural to astrocytic signatures (Lu et al., 2016). The gene discussed is OLIG2; the disease is central nervous system cancer.